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Abstract
Background: Sunscreens are being widely used to reduce exposure to harmful ultraviolet (UV)
radiation. The fact that some sunscreens are photounstable has been known for many years. Since
the UV-absorbing ingredients of sunscreens may be photounstable, especially in the long
wavelength region, it is of great interest to determine their degradation during exposure to UV
radiation. Our aim was to investigate the photostability of seven commercial sunscreen products
after natural UV exposure (UVnat) and artificial UV exposure (UVart).
Methods: Seven commercial sunscreens were studied with absorption spectroscopy. Sunscreen
product, 0.5 mg/cm2, was placed between plates of silica. The area under the curve (AUC) in the
spectrum was calculated for UVA (320–400 nm), UVA1 (340–400 nm), UVA2 (320–340 nm) and
UVB (290–320 nm) before (AUCbefore) and after (AUCafter) UVart (980 kJ/m2 UVA and 12 kJ/m2 of
UVB) and before and after UVnat. If theAUC Index (AUCI), defined as AUCI = AUCafter/AUCbefore,
was > 0.80, the sunscreen was considered photostable.
Results: Three sunscreens were unstable after 90 min of UVnat; in the UVA range the AUCI was
between 0.41 and 0.76. In the UVB range one of these sunscreens was unstable with an AUCI of
0.75 after 90 min. Three sunscreens were photostable after 120 min of UVnat; in the UVA range
the AUCI was between 0.85 and 0.99 and in the UVB range between 0.92 and 1.0. One sunscreen
showed in the UVA range an AUCI of 0.87 after UVnat but an AUCI of 0.72 after UVart. Five of
the sunscreens were stable in the UVB region.
Conclusion: The present study shows that several sunscreens are photounstable in the UVA
range after UVnat and UVart. There is a need for a standardized method to measure photostability,
and the photostability should be marked on the sunscreen product.
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Sunscreens give good protection against sunburn, actinic
keratosis and squamous cell carcinoma. The results for
preventing cutaneous malignant melanoma (CMM) and
basal cell carcinoma are less conclusive [1-3]. One expla-
nation for this can be that UVA radiation (320–400 nm)
plays a role for induction of CMM [4] and that it is mainly
in the UVA range the photodegradation of the sunscreen
occurs. In the present work, commercially available sun-
screens, containing organic chemical and/or inorganic
chemical filters, have been exposed to natural UV (UVnat)
as well as to artificial UV (UVart) in order to study their
photostability.
Previous studies have shown that some sunscreens lose
part of their protection when exposed to UV radiation [5-
10]. Several sunscreen producers claim that their products
give good protection against both UVA and UVB radia-
tion; however, the photostability of the product is rarely
declared. This is also important for the consumer to know
when choosing a sunscreen. Since it has been known for
several years that some products may be photounstable,
one would have expected a large improvement in the pho-
tostability of sunscreen products. Up to now, there is no
standard method for determining photostability of a sun-
screen [6,11,12]. Neither is there an international stand-
ard method for measuring UVA protection, and several
different systems are currently in use [13-16].
The aim of this study was to investigate the photostability
of commercial sunscreen products after UVnat and after
UVart.
Methods
Sunscreens
Seven commercial sunscreens were included, all available
on the Swedish market. Three sunscreens contained only
organic chemical filters, three sunscreens had a combina-
tion of inorganic and organic chemical filters, and one
sunscreen contained solely inorganic chemical filters. In
Table 1 the photoactive compounds of the sunscreens and
the Sun Protection Factor (SPF) of the product are shown.
The sunscreen was weighed and placed between two
plates of polished fused silica (quartz) with diameter 25
mm and thickness 5 mm. The amount applied was 0.5
mg/cm2. The absorbance was too high for proper meas-
urements when the recommended amount of 2 mg/cm2
was applied, causing distortion in the absorption spec-
trum. For this reason a thinner layer was applied. A previ-
ous study has shown that the result were independent
whether an application thickness of 1 or 2 mg/cm2 was
used [17].
Light sources
For UVA radiation, a UVASUN 2000 (MUTZHAS, Ger-
many) was used. The output is mainly between 340 and
400 nm.
For UV radiation (including UVB), an Esshå Corona Mini
(Sweden), equipped with two fluorescent tubes, Philips
TL 12 (20 W), was used. This is a broadband radiation
source from 280 to 380 nm with a major peak at 313 nm.
There are strong mercury peaks at 313 nm and 365 nm.
The irradiance at the exposure plane was measured with
an International Light IL 1350 Radiometer/Photometer
using a probe named SED 240 for UVA and a probe
named SED 015 for UVB radiation. The fluence rate of the
UVA lamp was 820 W/m2 when measured from a distance
of 25 cm. Twenty minutes' exposure gave a dose of 980 kJ/
m2. This corresponds to the UVA dose that reaches the
earth's surface during one sunny summer day in Gothen-
burg [18]. We also measured the spectral distribution of
the UVB lamp. By combining the spectral distribution
with the action spectrum of the probe, the fluence rate of
the UVB radiation was 9.8 W/m2. Twenty minutes of
exposure gave a dose of 12 kJ/m2 UV radiation (including
UVB). This corresponds to 45 Standard Erythema Doses
(SED) when further weighted by the CIE action spectrum
[19]. This is a much higher dose than normal for one sum-
mer day in Gothenburg [18] or what has been reported
from Denmark [20]. In spite of that fact, the majority of
sunscreens showed good stability in the UVB range. In
Table 2 the UV doses reported from the Swedish Metro-
logical and Hydrological Institute (SMHI) are listed.
For UVnat, samples were placed horizontally outdoors
when the weather was sunny. This was done in early July
in Gothenburg (latitude: 57° 42' N). The total exposure
time was 120 min (Table 2) with measurements of the
absorption spectra before exposure and after 30 min, 90
min and 120 min of UVnat. SMHI measures the global
irradiance in many places in Sweden and gives the CIE
erythema weighted UV radiation as well (Table 2).
To eliminate the possibility that the degradation of the
photoactive compounds could be caused by a tempera-
ture increase, control samples of sunscreen between silica
plates were placed on a heating plate for 20 minutes. The
temperature was kept at 50°C ± 2°C, which was the same
as that measured during exposure to the UVA lamp. This
is about 15°C higher than the temperature of the skin.
Spectra were recorded prior to and after heating. The tem-
perature did not influence the degradation since the
absorption spectra did not change after heating.Page 2 of 9
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In all studies the spectra were recorded by a Cary 4 spec-
trophotometer (Varian, USA). It is a two-beam spectro-
photometer without integrating sphere, which measures
the transmission by scanning over the wavelength range
of interest. Without integrating sphere the measured
absorbance includes also some scattered radiation. There-
fore, the spectra of samples with inorganic filters, which
scatter light, may show a too high absorbance.
Area under the curve index (AUCI)
The AUC for UVA, UVA1 (340–400 nm), UVA2 (320–340
nm) and UVB was calculated for each spectrum before
(AUCbefore) and after (AUCafter) UVart (980 kJ/m2 UVA
Table 2: The dose of natural UV radiation the investigated sunscreens received
Sunscreen Exposure time (min) UVA radiation (kJ/m2) Erythemal effective radiation (J/m2) SED
1 30 54 **
90 180 **
120 260 **
2 30 54 100 1
90 180 410 4.1
120 260 610 6.1
3 30 65 140 1.4
90 210 530 5.3
120 280 730 7.3
4 30 65 **
90 210 **
120 280 **
5 30 ** **
90 ** **
120 210 **
6 30 47 140 1.4
90 140 300 3.0
120 210 370 3.7
7 30 65 150 1.5
90 130 320 3.2
240* 570 1500 15
Data from the Swedish Metrological and Hydrological Institute (SMHI)
* The exposure time for Sunscreen 7 it was 30 min, 90 min and 240 min due to technical obstacles
** Data not available due to technical obstacles at SMHI.
Table 1: The photoactive compounds in the investigated sunscreens, CAS no and SPF of the product.
Photoactive compound CAS no Mainly protection against Active ingredients in the seven investigated sunscreen products
UVA UVB 1 2 3 4 5 6 7
EHMC 5466-77-3 x x x x
MBC 36861-47-9 x x x x
EHT 88122-99-0 x x
OC 6197-30-4 x x
BMDBM 70356-09-1 x x x x x x x
BZ-3 131-57-7 x x x
TLDCSA 90457-82-2 x x
TiO2 13463-67-7 x x x x x
ZnO 1314-13-2 x x
SPF 4 14 10 10 6 10 15
CAS Chemical Abstracts Service
EHMC ethylhexyl methoxycinnamate MBC 4-methylbenzylidene camphor
EHT ethylhexyl triazone OC octocrylene BMDBM butyl methoxydibenzoylmethane
BZ-3 benzophenone-3 TLDCSA terephthalylidene dicamphor sulfonic acid
TiO2titanium dioxide ZnO zinc oxide
SPF Sun Protection FactorPage 3 of 9
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and after UVnat. If the AUCI (AUCI = AUCafter/AUCbefore)
was >0.80, the sunscreen was considered photostable.
The AUC was calculated with the following equation:
where A is absorption and λ is wavelength. It was meas-
ured in steps of 1 nm.
For UVA λmax = 400 nm and λmin = 320 nm. The same cal-
culation was done for each UV range respectively, before
and after UVart and before and after UVnat.
Maier et al. used the difference between the spectral trans-
mission before and after a defined UV exposure, ΔT. A
product was labeled photounstable if the mean photoin-
stability was higher than 5% (1 mg/cm2 product was
used) [9]. In our study we chose the AUCI instead. Since
we used 0.5 mg/cm2 we considered the product photosta-
ble if the AUCI was higher than 0.8.
Results
Sunscreens
The photostability of the sunscreens tested varies consid-
erably. The photounstable sunscreens start to degrade
rather rapidly when exposed to the sun. After 30 min of
UVnat, Sunscreens 1 and 3 are unstable (AUCI <0.80).
Sunscreens containing inorganic chemical filters are more
photostable in our study than sunscreens with organic
chemical filters with the exception of Sunscreens 3 and 5
Sunscreens 5, 6 and 7 are photostable after UVnat; in the
UVA range the AUCI was between 0.85 and 0.99 after 120
min and between 0.92 and 1.0 in the UVB range. Sun-
screen 4 shows in the UVA range an AUCI of 0.87 after
UVnat but 0.72 after UVart.
Sunscreens 1, 2 and 3 are unstable. They show after 90
min UVnat an AUCI between 0.41 and 0.76 in the UVA
range and between 0.30 and 0.69 in the UVA1 range.
Sunscreens 2, 4, 5, 6 and 7 are stable in the UVB region
whereas Sunscreens 1 and 3 are not. During exposure,
absorption ranges of Sunscreens 1, 2 and 3 are shifted
towards shorter wavelengths (Fig. 1a–c).
In Table 3 the AUCI is presented.
This is true for all three samples, after both UVnat and
UVart. Sunscreen 4 is more unstable after UVart than to
UVnat (Fig. 2).
The spectra were normalized by dividing the maximum
value of the spectrum before irradiation by itself, so that
the peak value of the spectrum before irradiation was set
to 1.
The temperature was higher, during exposure to the UVart
than during exposure to UVnat, but the temperature did
not influence the absorption. Sunscreens 5, 6 and 7 were
stable both after UVart and after UVnat. Sunscreens 6 and
7 were very little influenced by UV exposure (Fig. 3a–c). In
agreement with findings from other studies, sunscreens
with the UV filter combination ethylhexyl methoxycinna-
mate (EHMC) and butyl methoxydibenzoylmethane
(BMDBM) were unstable [6,9,21,22].
Discussion
In most cases UVnat compared to the UVart gave qualita-
tively similar results. However, UVnat, with a lower flu-
ence rate than UVart, gave similar yields of degradation. In
addition, the fluence rate of the UVAart was higher than
that of the UVAnat, which could be expected to degrade
the sunscreens faster. But this is not the case, except for
Sunscreen 4. Since the dose of UVAart was higher than
UVAnat, Sunscreen 4 probably provides sufficient protec-
tion for the consumer.
Commercial sunscreens generally have low viscosity in
order to be easy to apply. The temperature increase of the
samples during UV exposure, especially after UVart, may
lower the viscosity further. This may result in reductions
of the optical path lengths of the samples. However, this
was not the case in our study since samples kept on a heat-
ing plate for 20 min at 50°C showed a similar spectrum
before and after heating.
Four of the seven sunscreens contain TiO2. If the particles
are too small they may lose their scattering effect and, con-
sequently, not give as good protection as larger particles.
This may be the case for Sunscreen 5 (Fig. 3a). Several
other studies show that inorganic chemical filters are not
always photostable [6,9-11]. Our study indicates the
opposite, but seven sunscreens are a quite small amount
of material, so this finding should be interpreted with cau-
tion.
When mixed with petrolatum, some sunscreens undergo
degradation during exposure to UV radiation, especially
in the UVA range [5]. This is also the case for one of the
most frequently used UV filters BMDBM. This compound
is included in six of the seven sunscreens studied here
(Table 1). Our results confirm the findings from other
studies that sunscreens containing the combination of
EHMC and BMDBM are photounstable, regardless of
what other UV filters they contain [6,9].
A λ λλ
λ ( )∑ ΔminmaxPage 4 of 9
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UV absorbance spectra of UVA photounstable sunscreens (AUCI <0.80)Figure 1
UV absorbance spectra of UVA photounstable sunscreens (AUCI <0.80). Before and after natural UV exposure (UVnat), and 
before and after artificial UV exposure (UVart). (a) Sunscreen 1 (b) Sunscreen 2 (c) Sunscreen 3.
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BMC Dermatology 2007, 7:1 http://www.biomedcentral.com/1471-5945/7/1Some manufacturers of sunscreens claim that commer-
cially available sunscreens are photostable because the
photoactive species are in a vehicle that stabilizes them.
This claim does not seem to be correct in several cases.
There are several studies about how improvement of pho-
tostability may be obtained, e.g. with nanoparticle encap-
sulation of EHMC [23], liposphere preparation of
BMDBM [24] or a combination with diethylhexyl
syringylidene malonate and BMDBM [25]. These findings
are very interesting and will hopefully lead to an improve-
ment in photostability in commercial available products.
When sunscreens without metallic oxide particles are
compared, Sunscreen 1 seems to be more rapidly
degraded than BMDBM dissolved in petrolatum. Not only
does the UVA protection decline after exposure, but also
the UVB protection. EHMC is one of the two UVB-absorb-
ing filters present in Sunscreen 2, and the only one in Sun-
screen 1. EHMC dissolved in petrolatum is rather
photounstable [5]. The vehicles of Sunscreens 1 and 2 are
nearly identical. The UVA-absorbing compound benzo-
phenone-3 (BZ-3) is added in Sunscreen 2. The presence
of this compound may stabilize BMDBM, in agreement
with earlier findings [26]. Another stabilizer that may
UV absorbance spectra of Sunscreen 4Figure 2
UV absorbance spectra of Sunscreen 4. Before and after natural UV exposure (UVnat), and before and after artificial UV expo-
sure (UVart). Sunscreen 4 was photostable when exposed to natural UV in the UVA range but not to UVAart.
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Table 3: Summary of the AUCI values for the investigated sunscreens
After natural UV exposure After artificial UV exposure
Sunscreen UVA UVA1 UVA2 UVB UVA UVA1 UVA2 UVB
30 
min
90 
min
120 
min
30 
min
90 
min
120 
min
30 
min
90 
min
120 
min
30 
min
90 
min
120 
min
1 0.72 0.46 0.36 0.69 0.38 0.29 0.83 0.65 0.54 0.91 0.87 0.81 0.36 0.32 0.45 0.69
2 0.84 0.76 0.75 0.83 0.69 0.67 0.86 0.92 0.97 0.86 0.92 0.97 0.63 0.53 0.88 0.89
3 0.67 0.41 0.41 0.59 0.30 0.34 0.81 0.58 0.52 0.92 0.75 0.63 0.40 0.31 0.58 0.73
4 0.92 0.86 0.87 0.91 0.85 0.83 0.94 0.91 0.91 0.95 0.93 0.95 0.72 0.69 0.81 0.83
5 0.96 0.89 0.85 0.94 0.87 0.83 0.99 0.95 0.93 0.99 0.99 0.98 0.90 0.88 0.97 0.97
6 0.98 0.94 0.94 0.97 0.93 0.93 0.98 0.96 0.97 0.99 0.99 1.00 0.85 0.82 0.92 1.00
7 0.99* 1.00* 0.96* 0.92* 0.99 0.99 1.00 0.99
The AUCI is defined as AUCafter/AUCbefore. The bold numbers show when AUCI is <0.80.
* Sunscreen 7 was exposed to natural UV during 240 min.Page 6 of 9
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UV absorbance spectra of UVA photostable sunscreens (AUCI >0.80)Figure 3
UV absorbance spectra of UVA photostable sunscreens (AUCI >0.80). Before and after natural UV exposure (UVnat), and 
before and after artificial UV exposure (UVart). (a) Sunscreen 5 (b) Sunscreen 6 (c) Sunscreen 7 was exposed to 240 min of 
UVnat.
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BMC Dermatology 2007, 7:1 http://www.biomedcentral.com/1471-5945/7/1work is anisotrizine (CAS no 187393-00-6)is [27]; how-
ever, that compound was not included in any of the prod-
ucts in this study. Sunscreen 2 also has a higher SPF.
However, a degradation manifesting itself in the UVA1
region should be noted.
Sunscreen 5 is photostable but does not contain any
metallic oxide particles. This may be due to a vehicle that
successfully prevents degradation and/or due to micro-
structures of the emulsion itself (Fig. 3a). It is interesting
to compare this spectrum with that of Sunscreen 3 (Fig.
1c) which, according to the list of contents, includes TiO2
particles but does not show the scattering slope. The size
of the particles may be too small (15 nm, according to the
producer) to influence the absorption spectrum in the vis-
ible range. Small particles of TiO2 are expected to give
maximal scattering in the UVB or UVC region. Larger par-
ticles can cause significant scattering also in the UVA and
visible region. It follows that the small nanoparticles can-
not give good protection in the UVA region in this case.
The peak between 350 and 375 nm in the absorption
spectra of Sunscreens 3, 4 and 5 (Figs. 1c, 2, 3a) can be
attributed to BMDBM. In view of this it should be noted
that the UV exposure makes the products react quite dif-
ferently. In Sunscreen 3 the BMDBM peak almost vanishes
totally after 30 min of UVnat, while the peaks in the other
two sunscreens are more stable. We suggested above why
there could be degradation in the UVA range in Sunscreen
3 despite the presence of TiO2 particles. The reported sta-
bilizing effect of 4-Methylbenzylidene camphor (MBC)
[26] does not manifest itself in the case of Sunscreen 3.
The photostable Sunscreen 6 contains, in addition to
BMDBM and TiO2, a third UVA absorber, terephthalyli-
dene dicamphor sulfonic acid (TLDCSA), which can stabi-
lize BMDBM. It has also been shown that TiO2 may
stabilize ketoprofen and may be used in protecting phot-
ounstable species [28].
Many commercial sunscreens give, according to the man-
ufacturers, good UVA and UVB protection. However, the
photostability of the sunscreen in the UVA range is not
always adequate. Most sunscreens offer good protection
against UVB while the UVA photostability of some prod-
ucts decreases substantially during UV exposure. The
potential toxicity of the photoproducts also needs to be
investigated further.
For the consumer it is very difficult to know what product
to choose, since the photostability varies between differ-
ent brands and the photostability is not marked on the
bottle. To know which photoactive compound the sun-
screen contains is not good enough. The stability also
depends on factors like preservatives, oxygen radical scav-
engers, and base formulation. It is not reasonable that the
ordinary consumer should have knowledge of this. If the
product claims to give broadband protection, this protec-
tion should remain also after sun exposure. The fact that
sunscreens are photounstable has been known for many
years. Our study clearly shows that there are still many
photounstable products on the market. When buying a
sunscreen, the consumer should automatically receive a
photostable product.
Conclusion
The present study shows that several commercially availa-
ble sunscreens are not photo stable. Degradation is clearly
manifested in the absorption region in the UVA range
after solar irradiation. In general, sunscreens with TiO2
particles seem to be more photostable, with Sunscreens 3
and 5 as exceptions. Special focus should be on the com-
monly used UVA absorber BMDBM. In three out of six
sunscreens in our study this molecule was degraded dur-
ing UV exposure. Stabilizers of BMDBM may work, but
not under all conditions. There is a need for a standard-
ized method to measure photostability and the photosta-
bility should be marked on the sunscreen product.
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